PCT-1

N/A

Report date: 2025/01/26 19:22:22

Base Information

Drug NamePCT-1

Drug Alias Nameautologous TCR T-cell therapy (Pan Cancer T)PCT-1

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapyBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionHuman leukocyte antigen modulators

TargetsHuman leukocyte antigen

Therapy Area/IndicationsTriple Negative Breast NeoplasmsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPan Cancer T BV

China Registration ClassN/A

Develop Information

Active CompaniesPan Cancer T BV

Inactive CompaniesN/A

Active IndicationsTriple Negative Breast NeoplasmsMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A